![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Use of Psychiatric Medication and Drug-Drug Interactions in Patients with HCV Infection Treated with Pangenotypic Direct-Acting Antivirals
|
|
|
AASLD 2022 Nov 4-8
Juan Turnes1, Antonio García-Herola2, Ramón Morillo-Verdugo3, Marinela Méndez4, Cristina de Alvaro4, Cándido Hernández5, Antoni Sicras-Mainar6
1Gastroenterology and Hepatology Department, CHU. Pontevedra, Spain; 2Digestive Medicine Department. Hospital Marina Baixa de Villajoyosa (Alicante), Spain; 3Hospital Pharmacy, Hospital de Valme, AGS Sur de Sevilla, Spain; 4Medical Affairs, Gilead Sciences S.L., Madrid, Spain; 5Global Medical Affairs, Gilead Sciences Europe Ltd, U.K; 6Health Economics and Outcomes Research, Atrys Health, Barcelona, Spain
![1114221](../images/111422/111422-17/1114221.gif)
![1114222](../images/111422/111422-17/1114222.gif)
![1114223](../images/111422/111422-17/1114223.gif)
![1114224](../images/111422/111422-17/1114224.gif)
![1114225](../images/111422/111422-17/1114225.gif)
![1114226](../images/111422/111422-17/1114226.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|